OOIR: Observatory of International Research

Papers

(The median citation count of Asian Journal of Pharmaceutical Sciences is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Ionic liquids as the effective technology for enhancing transdermal drug delivery: design principles, roles, mechanisms, and future challenges	923415346
Development of 3D bioprinting: From printing methods to biomedical applications	252
Alginate and alginate composites for biomedical applications	245
Antibacterial biomaterials for skin wound dressing	177
Recent trends on wound management: New therapeutic choices based on polymeric carriers	154
Tumor microenvironment responsive drug delivery systems	111
Size, shape, charge and “stealthy” surface: Carrier properties affect the drug circulation time in vivo	105
Plant-derived exosome-like nanoparticles and their therapeutic activities	104
The solute carrier transporters and the brain: Physiological and pharmacological implications	87
Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities	86
Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells	79
3D printed tacrolimus suppositories for the treatment of ulcerative colitis	73
Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects	73
Alginate‐based complex fibers with the Janus morphology for controlled release of co‐delivered drugs	72
Research and development of drug delivery systems based on drug transporter and nano-formulation	63
Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy	62
Use of graphene-based materials as carriers of bioactive agents	59
Drug-drug cocrystals: Opportunities and challenges	55
Nanoparticle cancer vaccines: Design considerations and recent advances	55
An overview on recent in vivo biological application of cerium oxide nanoparticles	53
Biointerface engineering nanoplatforms for cancer-targeted drug delivery	51
Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapy	50
Applications and developments of gene therapy drug delivery systems for genetic diseases	45
Application of chitosan-based nanoparticles in skin wound healing	45
Recent advances of biomimetic nano-systems in the diagnosis and treatment of tumor	45

A stepwise optimization strategy to formulate in situ gelling formulations comprising fluconazole-hydroxypropyl-beta-cyclodextrin complex loaded niosomal vesicles and Eudragit nanoparticles for enhanc	45
Microsponges for dermatological applications: Perspectives and challenges	43
Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation	42
Additive manufacturing of sustainable biomaterials for biomedical applications	42
Trends of nanotechnology in type 2 diabetes mellitus treatment	42
Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development	42
Nanomedicine potentiates mild photothermal therapy for tumor ablation	41
Aspects of high-performance and bio-acceptable magnetic nanoparticles for biomedical application	39
Advances in photosensitizer-related design for photodynamic therapy	39
Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment	37
The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy	37
Polymeric microneedle‐mediated sustained release systems: Design strategies and promising applications for drug delivery	37
Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance	35
Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid	35
Enhancement in antinociceptive and anti-inflammatory effects of tramadol by transdermal proniosome gel	33
Critical physicochemical attributes of chitosan nanoparticles admixed lactose-PEG 3000 microparticles in pulmonary inhalation	33
Intranasal delivery of paeoniflorin nanocrystals for brain targeting	33
Innovative color jet 3D printing of levetiracetam personalized paediatric preparations	32
Relationship and improvement strategies between drug nanocarrier characteristics and hemocompatibility: What can we learn from the literature	31
Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy	30
Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritis	29
Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than DoxilⓇ	26
Enhanced intestinal lymphatic absorption of saquinavir through supersaturated self-microemulsifying drug delivery systems	26
Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19	26
NIR-triggered thermo-responsive biodegradable hydrogel with combination of photothermal and thermodynamic therapy for hypoxic tumor	25
Glutamine transporters as pharmacological targets: From function to drug design	25
The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines	25
Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells	24
Macrophage membrane-mediated targeted drug delivery for treatment of spinal cord injury regardless of the macrophage polarization states	23
A pH-sensitive supramolecular nanosystem with chlorin e6 and triptolide co-delivery for chemo-photodynamic combination therapy	23
Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies	22
Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy	22
Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy	22
Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer	22
Heterobifunctional PEG-grafted black phosphorus quantum dots: “Three-in-One” nano-platforms for mitochondria-targeted photothermal cancer therapy	21
mRNA vaccines: Past, present, future	21
Anti-EpCAM functionalized graphene oxide vector for tumor targeted siRNA delivery and cancer therapy	21
Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated disorders	21
Fluidised bed granulation of two APIs: QbD approach and development of a NIR in-line monitoring method	21
Exosomes in cancer immunoediting and immunotherapy	21
Naringenin nanocrystals for improving anti-rheumatoid arthritis activity	20
In situ apolipoprotein E-enriched corona guides dihydroartemisinin-decorating nanoparticles towards LDLr-mediated tumor-homing chemotherapy	20
Recent advances in nanotherapeutics for the treatment and prevention of acute kidney injury	19
Advanced delivery strategies facilitating oral absorption of heparins	19
Sprinkle formulations—A review of commercially available products	19
Alantolactone-loaded chitosan/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment	19
Osteoimmunity-regulating biomaterials promote bone regeneration	19
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies	19
Fenton metal nanomedicines for imaging-guided combinatorial chemodynamic therapy against cancer	19
Rapid and effective treatment of traumatic spinal cord injury using stem cell derived exosomes	18

Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability	18
Enhanced delivery efficiency and sustained release of biopharmaceuticals by complexation-based gel encapsulated coated microneedles: rhIFNα-1b example	18
Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release	18
A biomimetic antitumor nanovaccine based on biocompatible calcium pyrophosphate and tumor cell membrane antigens	17
Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies	17
Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment	17
Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review	16
Enhanced photodynamic therapy/photothermo therapy for nasopharyngeal carcinoma via a tumour microenvironment-responsive self-oxygenated drug delivery system	16
Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo	16
Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy	16
3D printing‐based drug-loaded implanted prosthesis to prevent breast cancer recurrence post‐conserving surgery	15
Overcoming the cellular barriers and beyond: Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriers	15
An insight into the in vivo imaging potential of curcumin analogues as fluorescence probes	15
Chondroitin sulfate-mediated albumin corona nanoparticles for the treatment of breast cancer	15
Progress in drug delivery system for fibrosis therapy	14
Biomaterials reinforced MSCs transplantation for spinal cord injury repair	14
Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies	14
Quantitative prediction of the bitterness of atomoxetine hydrochloride and taste-masked using hydroxypropyl-β-cyclodextrin: A biosensor evaluation and interaction study	14
Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease	13
Innovative strategies for photodynamic therapy against hypoxic tumor	13
An understanding of mitochondria and its role in targeting nanocarriers for diagnosis and treatment of cancer	13
Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency	13
Sodium alginate and naloxone loaded macrophage-derived nanovesicles for the treatment of spinal cord injury	13
pH-activatable oxidative stress amplifying dissolving microneedles for combined chemo-photodynamic therapy of melanoma	13
In vitro - in vivo - in silico approach in the development of inhaled drug products: Nanocrystal-based formulations with budesonide as a model drug	12
Enhanced lysosome escape mediated by 1,2-dicarboxylic-cyclohexene anhydride-modified poly-l-lysine dendrimer as a gene delivery system	12
Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: Insights and future perspectives	12
PH-responsive strontium nanoparticles for targeted gene therapy against mammary carcinoma cells	12
Organic anion transporters also mediate the drug–drug interaction between imipenem and cilastatin	12
BioPerine Encapsulated Nanoformulation for Overcoming Drug-Resistant Breast Cancers	12
Effect of the structure of ginsenosides on the in vivo fate of their liposomes	12
Ocular prodrugs: Attributes and challenges	11
Elaborately engineering of a dual-drug co-assembled nanomedicine for boosting immunogenic cell death and enhancing triple negative breast cancer treatment	11
Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities	11
Changes in target ability of nanoparticles due to protein corona composition and disease state	11
Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy	11
Exosomes-mediated tumor treatment: One body plays multiple roles	10
Targeting the resolution pathway of inflammation using Ac2–26 peptide-loaded PEGylated lipid nanoparticles for the remission of rheumatoid arthritis	10
Exosomes: Emerging implementation of nanotechnology for detecting and managing novel corona virus- SARS-CoV-2	10
Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapy	10
A computer-aided chem-photodynamic drugs self-delivery system for synergistically enhanced cancer therapy	10
Unraveling GLUT‐mediated transcytosis pathway of glycosylated nanodisks	10
Sequentially releasing self-healing hydrogel fabricated with TGFβ3-microspheres and bFGF to facilitate rat alveolar bone defect repair	10
Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy	10
Regorafenib-loaded poly (lactide-co-glycolide) microspheres designed to improve transarterial chemoembolization therapy for hepatocellular carcinoma	9
Surface-engineered liposomes for dual-drug delivery targeting strategy against methicillin-resistant Staphylococcus aureus (MRSA)	9
Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis	9
Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases	9
New modular platform based on multi-adjuvanted amphiphilic chitosan nanoparticles for efficient lipopeptide vaccine delivery against group A streptococcus	9
Lignin-assisted construction of sub-10 nm supramolecular self-assembly for photothermal immunotherapy and potentiating anti-PD-1 therapy against primary and distant breast tumors	9
pH-sensitive micelles self-assembled from star-shaped TPGS copolymers with ortho ester linkages for enhanced MDR reversal and chemotherapy	8
Nucleobase-crosslinked poly(2-oxazoline) nanoparticles as paclitaxel carriers with enhanced stability and ultra-high drug loading capacity for breast cancer therapy	8
Exploring the potential of functional polymer-lipid hybrid nanoparticles for enhanced oral delivery of paclitaxel	8
Black phosphorus‐based nano‐drug delivery systems for cancer treatment: Opportunities and challenges	8
Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins	8
TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation	8